BRD2 and neoplasm: Furthermore, across all specimens, a global down regulation of miR-331-3p within the tumor samples relative to nonmalignant prostate was observed (Figure 1D), and 11 of these cases showed divergent miR-331-3p levels in the tumor and matched non-malignant adjacent tissue (NAT) (Supplementary Figure 1A).